Navigation Links
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
Date:12/10/2009

ends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceutical Inc. does not assume any duty to publicly update or revise the material contained herein.



                CHINA YONGXIN PHARMACEUTICALS INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                  AS OF SEPTEMBER 30, 2009 AND DECEMBER 31, 2008
                               (UNAUDITED)

                                                  September 30, December 31,
                                                       2009         2008
                      ASSETS
    Current Assets:
    Cash and cash equivalents                       $1,371,842     $609,422
    Accounts receivable, net                         6,622,395    6,030,874
    Notes receivable                                 3,074,753    1,334,078
    Other receivable, net                            2,823,356      356,573
    Advances to suppliers                            6,576,641    6,186,269
    Prepaid expenses                                        --      345,686
    Inventory, net                                   8,747,431    7,864,677
    Total Current Assets                            29,216,418   22,727,579

    Property and Equipment, net                      8,733,094    2,680,207

    Construction In Progress                           913,054    6,066,249

    Intangible Assets, net                              47,324       73,687
    Total Assets                                   $38,909,890  $31,547,722


'/>"/>
SOURCE China Yongxin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
(Date:7/28/2014)... 28, 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ... release its second quarter and year-to-date 2014 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . Arthur ... Charlotte C. Arnold , Vice President and Chief ...
Breaking Medicine Technology:ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
... 26, 2012  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today ... year 2011 financial and operating results on Thursday, February 16, ... host a conference call at 8:30 AM EST that day. ... be webcast online simultaneously.  A link to the webcast may ...
... PARK, N.J., Jan. 26, 2012  Armada Health Care, ... a joint development and marketing agreement that will ... specialty pharmacy software. Armada is a leading group ... providing services such as web-based therapy management and ...
Cached Medicine Technology:Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012 2Armada Health Care and Definitive Homecare Solutions Announce Alliance for Specialty Pharmacy Software and Services 2Armada Health Care and Definitive Homecare Solutions Announce Alliance for Specialty Pharmacy Software and Services 3
(Date:7/28/2014)... (PRWEB) July 28, 2014 Evolve Medical Clinics ... 2014, offering its members virtual visits and dramatic operational changes ... , Some estimates state that as many as 70% of ... “Imagine not having to leave your office or home for ... blood pressure or cholesterol,” CEO and Founder Michael R. Freedman, ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... Champions Cup Match between Manchester City and Liverpool FC ... Bronx has hosted countless big events since it opened several ... of the original Yankee Stadium, however, it has been a ... City metro area. , The Yankees Stadium is the ...
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s ... announce the release of the fourth edition of The ... Mark Underwood. , The Brain Health Guide is a ... for readers to improve memory and promote optimal aging. ... Brain Health Guide provides ways to help minimize common ...
(Date:7/28/2014)... Randy Dotinga HealthDay Reporter ... know it takes humans just milliseconds to look at someone,s ... a new study finds that certain facial features seem to ... The shape and size of the mouth, for example, appear ... are keys to attractiveness. The study findings suggest ...
Breaking Medicine News(10 mins):Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 2Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 4Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3
... The Men,s Health Policy,Center, a new resource center ... that they are hosting an online petition urging,Congress ... Services (CMS) practice,that unfairly restricts prostate cancer patients, ... people who are impacted by prostate cancer to,raise ...
... The Richard B. and,Lynne V. Cheney Cardiovascular ... have joined the Institute,s Board of Directors. As ... Institute., "Mary Matalin,s experience in public affairs ... Institute as we build our organization and educate,communities ...
... Have Choices and Flexibility ... Typically Available on Larger Plans, NEW YORK, March ... employees can now choose from a wider selection of dental ... The Guardian Life Insurance Company of America (Guardian), a ...
... 27, 2008 The Cardiovascular Research Foundation (CRF) will ... mortality rates for drug-eluting stents (DES) versus bare metal ... tomorrow evening in Chicago. , The analysiswhich includes ... team of researchers led by Ajay J. Kirtane, MD, ...
... relaxation response, a stress-management approach, to other lifestyle ... of hypertension most common in the elderly. ... Massachusetts General Hospital (MGH) Hypertension Program and the ... who received relaxation response training in addition to ...
... There is new promise on the horizon for ... according to researchers at the University of Toronto. ... twitches and muscle contractions during rapid eye-movement (REM) sleep, ... at the University of Toronto, discovered that an inhibitory ...
Cached Medicine News:Health News:Men's Health Policy Center Hosts Petition to Protest Government Barrier to Prostate Cancer Medications 2Health News:Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors 2Health News:Guardian Expands Dental Benefit Options Helps Small Business Owners Lower Insurance Cost 2Health News:Guardian Expands Dental Benefit Options Helps Small Business Owners Lower Insurance Cost 3Health News:Largest ever analysis of DES data demonstrates safety, efficacy in on-and-off-label use 2Health News:Relaxation training may improve control of hard-to-treat systolic hypertension 2Health News:Relaxation training may improve control of hard-to-treat systolic hypertension 3
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Medicine Products: